BI 695500 (rituximab biosimilar) / Boehringer Ingelheim  >>  Phase 3
Welcome,         Profile    Billing    Logout  

0 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BI 695500 (rituximab biosimilar) / Boehringer Ingelheim
No trials found

Download Options